This is a community-generated profile. If you would like to claim it, please .
OncoResponse discovers cancer immunotherapies by interrogating the human immune system
OncoResponse Funding
$0
22 rounds
OncoResponse has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on October 10, 2016.
Funding Rounds
A
$7000000Series AOct 2016
Investors of OncoResponse
GreatPoint Ventures
GreatPoint Ventures is an early-stage venture capital firm founded in 2015
Rounds
A
MD Anderson Cancer Center
global leader in cancer care, research, education and training, and prevention
Rice University
Early-stage VC firm investing in tech and healthcare companies
Rounds
U
MD Anderson
Rounds
U
Alexandria Real Estate Equities
Rounds
U
Baxalta
Rounds
U
ARCH Venture Partners
Rounds
U